Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy

Drug repurposing and combination therapy have been proposed as cost-effective strategies to improve Chagas disease treatment. Miltefosine (MLT), a synthetic alkylphospholipid initially developed for breast cancer and repositioned for leishmaniasis, is a promising candidate against Trypanosoma cruzi...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Julián Ernesto Nicolás Gulin, Margarita María Catalina Bisio, Daniela Rocco, Jaime Altcheh, María Elisa Solana, Facundo García-Bournissen
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2022-07-01
Serija:	Frontiers in Cellular and Infection Microbiology
Teme:	Chagas disease Trypanosoma cruzi miltefosine benznidazole drug combination chemotherapy drug repositioning
Online dostop:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.855119/full
Oznake:	Označite Brez oznak, prvi označite!